potentially implicate differences in the biological response or quality of care as risk factors not just for survival from infection but for overall life expectancy. However, no large study has simultaneously examined the role of all of these factors. Previous population-based studies using administrative databases had limited information regarding clinical characteristics (2, 7, 9, 10, 12) . Cohort studies generally record more clinical data, but published studies have several limitations, such as including patients with heterogeneous sources of infections (8, 10, 11, 13, 14) , being limited to those patients who were sufficiently ill to require admission to an intensive care unit (ICU) (14 -16) , being conducted at a single center (11) , or only examining shortterm outcomes (5, 8, 17) . Sex-related differences in immune response to infection have been mostly studied in young, proestrous animals and in young, healthy human volunteers (18) . These studies suggest that females have a proinflammatory immune profile, whereas males have an anti-inflammatory immune profile (18) . However, these results may not be generalizable to older adults with multiple chronic health conditions, who are at the highest risk of developing infections. Indeed, a small, single-center study of older subjects with sepsis found that tumor necrosis factor (TNF) concentrations were lower and interleukin (IL)-10 concentrations were higher among women, contrary to results in animals (5) .
We, therefore, analyzed data from a large prospective cohort study of older adults with CAP to determine whether differences in clinical characteristics alone explain the sex-related difference in survival. We chose CAP because by studying a single infectious process, we avoided the confounding effect of combining different sources of infection, the distribution of which varies by sex (2) . We examined sex-related differences in both short-term and long-term survival, and we compared quality of care and patterns of immune response, testing whether any identified differences explained differences in survival.
MATERIALS AND METHODS
Subjects and Design. We analyzed data from Genetic and Inflammatory Markers of Sepsis, a prospective multicenter observational cohort study. Subjects were enrolled in emergency departments (ED) of 28 academic and community hospitals in Pennsylvania, Connecticut, Michigan, and Tennessee from December 2001 to November 2003. Eligible patients were older than 18 years and had a clinical and radiologic diagnosis of CAP using criteria by Fine et al (19) . Exclusion criteria included transfer from another hospital, discharge from an acute care hospital within the previous 10 days, diagnosis of pneumonia within the previous 30 days, chronic dependency on mechanical ventilation, cystic fibrosis, active pulmonary tuberculosis, admission for palliative care, prior enrollment in the study, incarceration, and pregnancy. Institutional Review Boards of all participating hospitals approved the study, and written informed consent was obtained from all subjects.
Of the 2,320 subjects enrolled, we excluded 137 subjects because the clinical team ruled out CAP during the first 3 days of hospitalization. We restricted our analyses to the remaining 2,183 subjects.
Clinical Characteristics and Outcome. We prospectively collected detailed baseline and sequential clinical information using structured subject or proxy interviews, bedside assessment by study nurses, and from medical records. We classified subjects as insured if they had commercial health insurance, Medicare, or Medicaid coverage. We assessed comorbidity using the Charlson comorbidity score (20) . We assessed severity of illness on presentation using the Acute Physiology and Chronic Health Evaluation III (APACHE III) score and the Pneumonia Severity Index (PSI) (19, 21) . We also analyzed the acute physiology component of the APACHE III score separately, excluding points for age and chronic health conditions, to quantify physiologic derangements. We also analyzed the PSI score without points attributed to age, because this score assigns fewer age points to women than men. We defined severe sepsis as pneumonia with acute organ dysfunction following the 2001 International Consensus Criteria (22) . We defined acute organ dysfunction as a new Sequential Organ Failure Assessment (SOFA) score of Ն3 in any of six organ systems (23) . On the basis of Medicare quality monitoring system criteria (24) and the American Thoracic Society guidelines (25) , we compared quality of hospital care for CAP by assessing timing of initial antibiotic therapy and whether antibiotics were compliant with American Thoracic Society guidelines. We also compared measures of therapeutic intensity by noting whether patients were admitted to hospital and to ICUs; and for subjects admitted to an ICU, utilization of various treatments. We ascertained 1-year survival and cause of death by National Death Index search and using National Death Index-coded causes of death (26) . The reliability of National Death Index for epidemiologic studies has been previously validated (27) .
Laboratory Procedures. We assessed differences in the immune response to infection by comparing circulating concentrations of biomarkers at ED presentation and during the first week of hospital course within inflamma-tory (TNF, IL-6, IL-10), coagulation (factor IX, thrombin-antithrombin complex, antithrombin III), and fibrinolysis (plasminogen activator inhibitor-1, and D-dimer) systems. Our choice of markers was based on two considerations: earlier evidence of association between the biomarker and outcome (28, 29) , and logistics, such as stability of the marker, ease of assay, and costs. Blood was collected at enrollment and, for admitted patients, daily for the first week and weekly thereafter until hospital discharge or day 28. We did not obtain samples in ED from subjects presenting after 11 PM, or on weekends or holidays for logistic reasons. Details of sample processing have been described previously (30) . We analyzed inflammatory biomarkers using an automated chemiluminescent immunoassay analyzer (IMMULITE, Diagnostic Products Corp., Los Angeles, CA). Coagulation and fibrinolysis biomarkers were analyzed in a randomly selected subset by a commercial laboratory (Essoterix, Agoura Hills, CA). Thus, we analyzed inflammatory biomarkers in 1429 and coagulation and fibrinolysis biomarkers in 734 subjects.
Statistical Analyses. We conducted univariate comparisons using chi-squared tests, Student's t tests, or their nonparametric equivalents, as appropriate. We conducted multivariable analyses using generalized linear models for severity of illness, logistic regression model for risk of severe sepsis, mixed models for biomarkers, generalized estimating equation models for quality of care, and Cox proportional hazards models for survival analyses. We selected variables from demographic, health behavior, and chronic health domains for multivariable analyses if they were significant in the univariate analysis (p Ͻ 0.1). For quality of care models, we also adjusted for initial severity of illness. For survival analyses, we calculated hazard ratios (HR) for serial models, initially constructing a model without covariates and then adjusting for demographics, health behavior, and chronic health domains. We used mixed models to compare biomarkers to account for correlation of repeated measures over time and Tobit models to account for truncated data (31) . We used generalized estimating equation models where hospital characteristics were treated as a cluster-level covariate to compare quality of care, because care quality for subjects treated within the same hospital may be correlated. For the logistic regression and Cox proportional hazards models, we conducted additional analyses to assess whether the association between sex and outcomes was affected by hospital characteristics by incorporating these factors as fixed effects. We compared survival for different time intervals after occurrence of CAP using a Gray's model (32) for 1 year and at earlier time points at 30 and 90 days. To assess if menopausal status influenced differences in survival, we compared survival among men and women stratified by age.
We used two approaches to assess if sex differences in inflammatory, coagulation, and fibrinolysis biomarkers explained differences in survival. First, we examined change in HR in survival models incorporating variables from demographics, health behavior, and chronic health domains and then additionally adjusting for inflammatory, coagulation, and fibrinolysis biomarkers that differed between men and women. Second, we examined the sex differences in ED concentrations of the biomarkers that differed between men and women, adjusted by survival status. ED concentrations of biomarkers were associated with survival for different time points, and a Gray's model was used to identify the time point at which the biomarker was no longer associated with differences in outcome.
Analyses were performed using SAS 9.0 (SAS Institute, Cary, NC) assuming statistical significance at p Ͻ 0.05. We estimated that a sample size of 1800 men and women would be required to show a 5% absolute difference in 1-year mortality (␤ ϭ 0.8 and ␣ ϭ 0.05).
RESULTS
Prehospitalization Characteristics. Of the 2,183 subjects, 1,136 were men and 1,047 were women ( Table 1 ). The mean age of both sexes in the cohort was 64.9 years. Approximately half of all subjects were recruited from EDs of large (Ն250 beds) teaching hospitals. Smoking was more prevalent among men compared with women (70.9% vs. 58.3%, p Ͻ 0.0001). Men were more likely to have at least one chronic health condition, based on their Charlson score (70% vs. 65.5%, p ϭ 0.03). In particular, cardiac disease, acquired immunodeficiency syndrome, and neoplastic disease were more prevalent among men. Approximately half the subjects who reported vaccination status had received a pneumococcal or influenza vaccine. Men were more likely to have received an influenza vaccine, but no differences were seen in pneumococcal vaccination between men and women.
Most subjects had health insurance, although men were less likely to have health insurance (92.7% vs. 95.8%, p ϭ 0.002). Only 5.6% of subjects had a "do not resuscitate" order before hospitalization; again, this was less frequent among men (4.7% vs. 6.7%, p ϭ 0.04). Men were less likely to have received antibiotics before presentation to the ED. On average, symptoms were present in men for a slightly longer time (5.1 vs. 4.7 days for men and women). Following evaluation in the ED, 288 (13.2%) subjects were discharged home and 1895 (86.8%) required hospital admission. An equal proportion of men and women were hospitalized (86.7% vs. 86.9%, p ϭ 0.89). COPD, chronic obstructive pulmonary disease; IQR, interquartile range. a Data were missing for fewer than 5% of cohort for most variables. . Data were missing in five subjects for TNF, three subjects for IL-6, and nine subjects for IL-10. B, Coagulation biomarkers (factor VII, antithrombin III, and thrombin-antithrombin complexes). Data were missing in two subjects for factor VII and four subjects for thrombin-antithrombin complexes. C, Biomarkers of fibrinolysis (plasminogen activator inhibitor (PAI)-1 and D-dimer). Data were missing in one subject for PAI-1 and two subjects for D-dimer. p values are shown for differences in day 1 concentration for each biomarker and adjusted for age, race, Charlson score, insurance, and smoking status.
Severity of Illness and Severe Sepsis. At presentation to the ED, men had greater illness severity, reflected by higher mean physiology components of the APACHE III score (38.8 vs. 37.2, p ϭ 0.02). These differences were small but remained significant when adjusted for age, race, Charlson score, and smoking, vaccination, insurance, and resuscitation status (p ϭ 0.02). Men had higher PSI scores compared with women (100.3 vs. 86.5, p Ͻ 0.0001), and this difference persisted when PSI scores were compared without points for age (35.3 vs. 31.6, p ϭ 0.004).
Severe sepsis occurred in 588 (31%) subjects. Of these, approximately half had severe sepsis on the first day of hospitalization, and in 85% cases it occurred by the fourth day after presentation. Men had higher risk of severe sepsis compared with women (29.2% vs. 24.5%, unadjusted odds ratio ϭ 1.3, 95% confidence interval [CI] 1.1-1.5, p ϭ 0.01) ( Table 2 ). The odds ratio remained unchanged, but did not remain statistically significant, when adjusted for age, race, Charlson score, and smoking, vaccination, insurance, and resuscitation status (adjusted odds ratio ϭ 1.2, 95% CI 0.99 -1.5, p ϭ 0.07). The incidence of cardiac, respiratory, neurologic, coagulation, and liver dysfunction was similar, but men were more likely to have renal dysfunction compared with women ( Table 2 ). The median length of hospital stay was similar among men and women (5 days in each case, p ϭ 0.84).
Immune Response. On presentation to the ED, inflammatory biomarkers, including TNF, IL-6, and IL-10, were higher among men compared with women ( Fig. 1) . Coagulation biomarkers, such as antithrombin-III and factor IX, were lower among men, but no differences were seen in thrombin-antithrombin complexes. Fibrinolysis biomarkers, such as D-dimer concentrations, were higher among men, but plasminogen activator inhibitor-1 concentrations were similar for both groups. On ED presentation, men had lower platelet count compared with women. The median (interquartile range) platelet count, expressed as 10 3 cells/mm 3 , for men and women were 224 (169 -285) and 264.5 (205-339) (p ϭ 0.005), respectively. These differences remained significant when adjusted for age, race, Charlson score, insurance, and smoking status ( Fig. 1) .
Quality and Intensity of Care. Compared with women, men were more likely to receive antibiotics within 4 and 8 hours after presentation to the ED, but results were statistically significant in the univariate analyses only at 8 hours (Table  3 ). This association remained significant when adjusted for age, race, Charlson score, insurance status, physiology components of the APACHE III score, and hospital characteristics (teaching status and bed size) (p ϭ 0.01). Similar trends were seen when analyses were stratified by PSI scores (Table 3) . No sex differences were found in compliance of antibiotic therapy with American Thoracic Society guidelines.
With one exception, no sex-related differences in the intensity of hospital care were observed. Equivalent proportions of men and women were admitted to hospital after evaluation in the ED (Table 3) . Men were almost twice as likely to be initially admitted to the ICU after evaluation in ED (4.4% vs. 2.2%, p ϭ 0.007 for men and women), perhaps because of the observed higher illness severity among men. However, no differences were seen in ICU utilization during hospital stay. Once admitted to the ICU, no differences were seen in the use of pulmonary artery catheters or mechanical ventilation. Use of comfort measures or do not resuscitate orders were also similar for both groups.
Survival. Men had a higher risk of death at earlier time points, such as 30 days (7% vs. 4.5%, p ϭ 0.01) and 90 days (11.4% vs. 8.6%, p ϭ 0.02), and at 1 year (21% vs. 16%, p ϭ 0.002). The HRs were similar for ten consecutive time intervals during 1 year (data not shown). Men had a higher risk of death compared with women for 1 year (HR ϭ 1.35, 95% CI 1.11-1.65, p ϭ 0.003) (Fig. 2) . The HR remained unchanged and the association was significant when adjusted for age, race, smoking, resuscitation, insurance, vaccination status, Charlson comorbidity index, and physiology components of the APACHE III score (adjusted HR ϭ 1.29, 95% CI 1.05-1.59, p ϭ 0.004). Hospital site or hospital characteristics were not significant predictors in any model, and the addition of these variables to the models did not change the risk estimates (data not shown).
We analyzed risk of death stratified by severe sepsis occurrence, age (younger and older than 50), smoking status, and Charlson score (Table 4 ). For each analysis, the stratified odds ratios of death at 1 year were similar to those seen in the full analyses, suggesting that severe sepsis occurrence, age, smoking status, and chronic health conditions did not influence the association between sex and risk of death.
Causes of death were different between men and women (p ϭ 0.005) ( Table 5 ). Men were more likely to die because of cardiovascular disease (32.2% vs. 24.4%) and cancer (26.8% vs. 17.1%), and women were more likely to die because of chronic lower respiratory disease (20.7% vs. 11%).
Immune Response and Sex Differences in Survival. For biomarkers that differed between men and women in the ED, patterns of circulating concentrations of these biomarkers were associated with survival at different time points. Lower concentrations of factor IX were associated with lower survival for 30 days; higher concentrations of IL-6 and IL-10 were associated with lower survival for 180 days; and higher TNF and D-dimer and lower antithrombin-III were associated with lower survival for 1 year (p Ͻ 0.05, data not shown). Compared with the HR (men vs. women) estimated in the unadjusted model and the model adjusted for demographics, health behaviors, comorbidities, and illness severity, the HR in the model additionally adjusted for biomarkers that differed between men and women were no longer statistically significant (adjusted HR ϭ 1.27, 95% CI 0.9 -1.8, p ϭ 0.17). Table 6 shows ED concentrations among survivors and nonsurvivors adjusted by sex. In this adjusted analysis, the magnitude of difference was similar between men and women in the groups who did and did not survive. However, the patterns of TNF, IL-6, IL-10, D-dimer, antithrombin-III, and factor IX observed among men were associated with worse survival.
DISCUSSION
In a large, multicenter cohort of older adults, we found that men with CAP were less likely to survive after an infection compared with women. This difference was not explained by differences in demographics, health behavior, chronic health conditions, and quality of care. Biological response to CAP was different among men and women, with higher proinflammatory (TNF, IL-6) and anti-inflammatory (IL-10) biomarkers, decreased circulating concentrations of coagulation factors, including antithrombin III and factor IX, and increased D-dimer, suggesting greater fibrinolysis among men. Although the magnitude of differences in biomarker concentrations were similar between survivors and nonsurvivors among men and women, the patterns of inflammatory, coagulation, and fibrinolysis markers among men were more likely to be associated with worse outcomes in our analyses and previous studies (28, 30) . To our knowledge, this study is the largest study comparing biological response to infection between men and women. Our results suggest that immune response to infection is an important target for interventions to reduce sex disparities in the outcome of infection.
Earlier studies suggest that potential reasons for lower life expectancy of men include higher prevalence of risk-taking behavior and higher burden of chronic diseases. In our study, men were more likely to smoke and had higher burden of chronic health conditions. Yet, the higher HR for men was not attenuated and remained statistically significant when adjusted for these risk factors. Men presenting with CAP of an equivalent illness severity to women were also more likely to die, because the survival difference was not explained by adjustment for physiologic derangements on presenta- tion. Furthermore, sex-related differences in survival following CAP occurred at earlier time points, during the acute illness, and these differences persisted for 1 year, when subjects appeared to have recovered from the acute illness. Previous studies showing increased susceptibility to infection for men (1) and our results demonstrating worse long-term survival following an acute infection have important implications for the understanding of sexrelated differences in life expectancy.
A key finding of our study is that the inflammatory, coagulation, and fibrinolysis responses to infection on presentation to the ED differ between men and women and are independent of age, chronic health, and smoking status. There are several possible explanations for the differences observed. First, sex hormones have been suggested to play a role, but are less likely to be important because most women in our study were postmenopausal, and the pattern of immune response in our study is different from those reported in proestrous animals. However, a recent study by May et al (33) suggested that estradiol concentrations are higher in older women compared with men during critical illness. We did not measure levels of sex hormones in our study. If sex hormones do play a role in older adults, we speculate that they may modify immune response when subjects are exposed to infection and before hospitalization. Second, the pattern of immune response may reflect the higher severity of illness we observed among men. Third, there is an increasingly recognized interaction between acute infection and chronic disease (34) , implying that differences in immune response could occur because men had more chronic health conditions. Fourth, microbiologic factors, such as qualitative or quantitative differences in infection burden because of smoking, may lead to higher inflammatory and lower coagulation biomarkers. Finally, cellular mosaics in women due to differential inactivation of the paternal and maternal X-chromosomes in different cells and genes related to inflammation present on them, such as IL-1 receptor-associated kinases-1, may influence immune response (18, 35, 36) .
In addition to examining differences in survival and immune response, we also examined differences in severity of illness and quality of care. We showed small differences in the severity of illness between men and women at presentation to the ED. Men presented approximately half a day later after the onset of symptoms and were less likely to receive antibiotics before presenting to the ED. Whether these differences reflect patient preferences or occurred because lower proportion of men had health insurance, and whether these differences account for higher severity of illness on presentation to the ED is less clear. We also showed a small difference in quality of care. Men were more likely to receive antibiotics within 8 hours despite adjusting for hospital characteristics and severity of illness. Although we could not assess if antibiotic therapy was delayed because of differences in clinical presentation of CAP, if anything, this difference would favor a better outcome for men.
Our study had several strengths. First, our finding of lower male survival was independent of hospital characteristics and observed in 28 academic and community hospitals in four geographic regions of the United States. Second, we adjusted for several factors that could confound this association, including risk factors in the demographic, chronic health, and health behavior domains. Furthermore, the higher risk of death persisted when we adjusted for differences in the initial severity of illness between men and women. We showed that the higher risk of death for men was similar in subjects with and without severe sepsis and those with and without chronic health conditions. Although we cannot exclude residual confounding due to subclinical disease, these risk factors are likely to be more prevalent among women (37) . Third, by considering subjects with CAP alone, we avoided confounding associated with different types of infection. Our results differ from previous cohort studies that recruited subjects after surgery and trauma (8, 10, 11) . Compared with our cohort, these subjects have different characteristics, including differences in age, health behaviors, and chronic health conditions. These studies often did not adjust for differences in illness severity. Furthermore, they examined outcomes of hospitalacquired infection in contrast to community-acquired infection, with different etiological agents and predisposing factors.
Our study has limitations. First, we cannot ascribe cause-effect relationship TNF, tumor necrosis factor. a Using a Gray's model, we showed that concentrations of different biomarkers were associated with survival for different time periods. Emergency department concentrations of factor IX were associated with survival for 30 days, interleukin-6 and interleukin-10 with survival for 180 days, and TNF, antithrombin-III, and D-dimer with survival for 1 yr. Concentrations of these biomarkers among survivors and nonsurvivors at the corresponding time points, stratified by sex, are shown. to specific biomarkers, and mediators upstream in the immune response could explain these differences. Second, we measured a broad panel of biomarkers but several other biomarkers could play an important role in explaining sex differences in outcomes of CAP. Finally, our results cannot be generalized to noninfectious conditions or other infections because sex differences could manifest differently with different infections.
In summary, we were unable to explain the higher male mortality from CAP on the basis of differences in clinical characteristics or quality of care. We observed different patterns of activation of the inflammatory, coagulation, and fibrinolysis systems between men and women, and these patterns were associated with short-term and long-term survival differences between men and women.
